- Research article
- Open Access
Multiparametric CMR imaging of myocardial structure and function changes in diabetic mini-pigs with preserved LV function: a preliminary study
BMC Cardiovascular Disorders volume 22, Article number: 143 (2022)
The purpose of this study is to dynamically monitor the myocardial structure and function changes in diabetic mini-pigs by 1.5 T cardiac magnetic resonance.
Three male mini-pigs underwent cardiac magnet resonance (CMR) imaging, and histologic examination. T1-mapping was acquired at basal, mid and apical segments. CMR feature-tracking (CMR-FT) is used to quantify left ventricle global longitudinal (LVGLS), circumferential (LVGCS) and radial strain (LVGRS). Epicardial adipose tissue (EAT) was evaluated using a commercially available software.
Left ventricular mass (LVM), myocardial native T1 value, extracellular volume (ECV) value and EAT were increased gradually after 6 months of modeling, while LVGLS decreased gradually after 6 months of modeling (LVM: 24.5 (23.4, 26.7) vs. 42.7 (41.4, 44.6) g/m2, p < 0.001; Native T1: 1005.5 (992.6, 1010.7) vs. 1028.7 (1015.5, 1035.6) ms, p = 0.041; EAT: 16.1 (14.5, 18.2) vs. 24.6 (20.8, 26.9) mL, p = 0.020; ECV: 21.4 (20.2, 23.9) vs. 28.9 (26.7, 30.3) %, p = 0.011; LVGLS: − 22.8 (− 21.4, − 23.9) vs. − 17.4 (− 17.2, − 19.2)%, p = 0.008). The diffuse myocardial interstitial fibrosis was found in histology samples.
The progressive impairments in LV structure and myocardial deformation occurs in diabetic mini-pigs. T1 mapping and CMR-FT technology are promising to monitor abnormal changes of diabetic myocardium in the early stage of diabetic cardiomyopathy.
In 2010, the prevalence of diabetes among adults (20–79 years old) was 6.4%, reaching 285 million people, but the prevalence rate will increase to 7.7%, and the number will reach 439 million in 2030 . Diabetes mellitus (DM) is an important risk factor for the morbidity and mortality of cardiovascular diseases, which seriously endangers human health and aggravates the social burden. Diabetic cardiomyopathy (DCM) is a specific myocardial disease that excludes hypertension or coronary artery disease and causes cardiac structural and functional abnormalities in patients with long-term insulin resistance or hyperglycemia [2, 3]. Many pathological mechanisms promote apoptosis, necrosis and diffuse fibrosis of diabetic cardiomyocytes, and eventually lead to cardiac dysfunction and heart failure . Epicardial adipose tissue (EAT) also plays a particularly important role in diabetes mellitus and cardiovascular physiology. EAT excretes several pro-inflammatory chemokines and cytokines, collectively called adipokines, been shown to impair cardiomyocyte contractile function and fat oxidation . Therefore, early detection of myocardial fibrosis, cardiac dysfunction and EAT and its effective intervention is very important for the prevention and treatment of diabetic cardiomyopathy.
Cardiac magnetic resonance (CMR) cine imaging is the gold standard for evaluating myocardial structure and function in many cardiac diseases. In recent years, as a new and sensitive technique of measuring myocardial deformation and function, CMR tissue tracking (CMR-FT) method based on the cine images has been widely used in myocardial strain analysis of different types of cardiomyopathy [6, 7], and it can also provide important value for prognosis analysis of cardiomyopathy . Besides, CMR T1/extracellular volume (ECV) mapping techniques are of great importance in the diagnosis and treatment evaluation of various heart diseases for their non-invasive early quantitative and monitoring of myocardial focal and diffuse lesions.
So far, the researches on diabetic cardiomyopathy mainly focus on patients with type 2 diabetes . However, few studies have been done on animals with type 1.5 diabetes model (a combination of type 1 and type 2 DM). In this study, we use mini-pigs to simulate type 1.5 DM model and to evaluate its influence on myocardial structure and function by using a variety of advanced CMR quantitative techniques.
All animal experiments were approved by Institutional Animal Care and Use Committee, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China and were executed conforming to the “Guide for the Care and Use of Laboratory Animals” and in compliance with the ARRIVE guidelines. Three male mini-pigs, aged 5–6 months, were provided by the Laboratory Animal Center of Tongji Medical College. Type 1.5 DM animal models were induced by intravenous injection of streptozotocin at a dose of 150 mg/kg . Fasting blood glucose was continuously measured with a glycemeter at pre-determined time points. Sustaining fasting blood glucose levels > 250 mg/dL were considered as having diabetes . Their weight ranged from 20 to 24 kg at the beginning and increased to 28–30 kg at the end of this study. At 6 months, after non-invasive imaging the pigs were anaesthesia through intravenous injection of overdoses of 3% pentobarbital sodium (6 mg/kg). The pigs were sacrificed under unconscious (no pedal reflex and no blink reflex, no response to painful stimuli) using the blood-letting method for histologic analyses.
CMR scanning protocol
The mini-pigs were anesthetized through intravenous injection of pentobarbital sodium (0.1 mg/kg min). All three pigs have a pre-DM scan in our study, and all pigs have a post-DM scan at 1.5, 3, 4.5 and 6 months. Hematocrit level (HCT) was measured by collecting blood from ear vein before MR scanning was performed.
All three pigs underwent a standard CMR examination with a 1.5 T scanner (MAGNETOM Aera, Siemens Healthcare, Erlangen, Germany). A balanced steady-state free procession (b-SSFP) sequence was performed to acquire left ventricular long-axis and short-axis (coverage from the base to the apex segment) cines. The parameters included: repetition time, 2.93 ms; echo time, 1.16 ms; flip angle, 80°; slice thickness, 6 mm; field of view, 340 × 255 mm2; and matrix, 256 × 205. T1 mapping technique was performed at the basal, mid and apical slices of the left ventricular short axis before and 15 min after the administration of gadolinium-diethylenetriamine pentaacetic acid (DTPA) (0.2 mmol/kg, Magnevist; Bayer Healthcare; Germany) using a prototype-modifed Look-Locker inversion recovery (MOLLI) sequence. The following parameters were used: repetition time, 3.89 ms; echo time, 1.12 ms; flip angle, 35°; slice thickness, 8 mm; field of view, 360 × 270 mm2; matrix, 256 × 192; iPAT factor, 2; and acquisition scheme, 5b(3b)3b. The ECV mapping image is generated automatically by inputting the value of HCT through a prototype inline processing function from Siemens, based on native and post-contrast T1 mapping at the same slice and the subject-specific HCT value.
MR data analysis
Argus software (Syngo MMWP VE30A workstation, Siemens) was used to analyze cardiac structure and function. The basic parameters of cardiac function, including left ventricular end-diastolic volume (LVEDV); Left ventricular end-systolic volume (LVESV);Left ventricular ejection fraction (LVEF); Left ventricular mass (LVM). In order to avoid the influence of partial volume effect, the native T1 and ECV values were measured by manually sketching the region of interest (ROI) in the interventricular septum myocardium of the left ventricular basal, middle and apical segments (Fig. 1). EAT was manually traced on contiguous end-diastolic short axis slices from the base to the apex using a dedicated commercial software (CVi42; Circle Cardiovascular Imaging Inc., Calgary, Alberta, Canada) (Fig. 2). EAT measurement was performed according to the method described by Cai et al. .
Myocardial systolic strains were analyzed and processed using commercial cardiovascular postprocessing software (Medis 3.0, Netherlands) to obtain global measurements of LV strain. All the continuous short axis films and two-,three-, and four-chamber long-axis images were imported into Medis 3.0 software offline. At the end of diastole, the left ventricular endocardial and epicardial contours were manually delineated on the short axis and the long axis respectively. The trabecular and papillary muscles were included within the heart cavity (Fig. 3A–C). The left ventricle global longitudinal (LVGLS), circumferential (LVGCS) and radial strain (LVGRS) were calculated by automatically tracking the contours in each cardiac cycle.
At 6 months, after MR scanning, three pigs were sacrificed, and the hearts were collected and fixed in 10% formalin. After dehydration and embedding, sectioning was conducted and the corresponding part was selected in the interventricular septum myocardium, with a slice thickness of 5 μm, followed by Masson stainin.
All data were statistically analyzed using standard statistical software (SPSS 21.0 for Windows, IBM, Chicago, IL, USA). Continuous variable are presented as median and range (lowest and highest). One way analysis of variance (ANOVA) was used to compare baseline and the value of the relevant index at 6 months. For all comparisons, statistical significance was considered at a p value < 0.05.
The LV strain of three mini-pigs were analyzed independently by two experienced observers. One observer made another analysis after 14 days. The repeatability of parameters within and between observers were calculated respectively. By calculating the inter class correlation coefficient (ICC), the repeatability of multiple measurements was analyzed.
MRI characteristics and myocardial strain indexes of diabetic mini-pigs
All the three miniature pigs were successfully modeled, and there were no statistically significant differences in LVEDV, LVESV, LVEF, LVGRS and LVGCS before and after the DCM model (Table1). LVM, LV remodeling index, native T1, ECV value, LVGLS, and EAT were increased at the 6th months of modeling compared to the baseline (LVM: 24.5 (23.4, 26.7) vs. 42.7 (41.4, 44.6) g/m2, p < 0.001; LV remodeling index: 0.8 (0.7, 0.9) vs. 1.7 (1.6, 1.7), p < 0.001; Native T1: 1005.5 (992.6, 1010.7) vs. 1028.7 (1015.5, 1035.6) ms, p = 0.041; EAT: 16.1 (14.5, 18.2) vs. 24.6 (20.8, 26.9) mL, p = 0.020; ECV: 21.4 (20.2, 23.9) vs. 28.9 (26.7, 30.3) %, p = 0.011; LVGLS: − 22.8 (− 21.4, − 23.9) vs. − 17.4 (− 17.2, − 19.2)%, p = 0.008) (Table 1, Fig. 4).
Histological analysis of myocardial alterations
At the 6th months of modeling, gross anatomy of diabetic model pig heart showed left ventricular wall hypertrophy (Fig. 5A, B), Masson staining of myocardium showed diffuse myocardial interstitial fibrosis (Fig. 5C).
The intraclass correlation coefficient (ICC) values of nativeT1, ECV, EAT, LVGRS, LVGCS and LVGLS measured by the same physician were 0.974, 0.957, 0.945, 0.985, 0.869 and 0.934 respectively. The ICC values of nativeT1, ECV, EAT, LVGRS, LVGCS and LVGLS were 0.969, 0.973, 0.948, 0.981, 0.893 and 0.926 respectively, measured by two different physicians.
This animal model simulates the type 1.5 DM model of human disease, the advantages of this model not only avoid the effect of various confounding factors in patients on diabetic cardiomyopathy, such as age, the course of the disease, and coexisting diseases, but also obtain the imaging indicators of myocardial fibrosis by non-invasive imaging method and compare them with myocardial histological alterations to insight into the pathogenesis of DCM. The main findings of this study were that (1) the increases of myocardial T1 value, ECV and LVM and the decrease of left ventricular GLS were found at the 3rd months of modeling, and (2) EAT abnormalities were observed at the 6th months of modeling compared to the base line.
T1 mapping can early monitor myocardial focal and diffuse fibrosis by quantifying myocardial T1 and extracellular volume values, and it has been confirmed in previous histological studies . Our results showed that T1 and ECV values of diabetic animal models increased gradually with the prolongation of DM course after 3 months of modeling, which was consistent with the study has been published on T2DM patients . However, the myocardial ECV studied by Sorensen et al.  was not confirmed by myocardial biopsy. Due to pigs have many similarities with humans in anatomy, metabolism, physiology and pathophysiology, our findings in histological biopsy samples also lends credence to their findings. There are many factors causing this myocardial damage, including many molecular mechanisms. Animal studies in vivo have shown that hyperglycemia leads to cardiomyocyte apoptosis through the activation of reactive oxygen species (ROS) , which in turn can induce the formation of end glycation end products and eventually lead to myocardial fibrosis . These findings also provide the supports for our experimental results. After 3 months’ modeling, T1 value and ECV value gradually increased with the extension of diabetes duration, which was consistent with the results of Zeng , indicating that the longer the course of diabetes, the higher the degree of myocardial fibrosis. One possible explanation is that the long term chronic hyperglycemia may aggravate myocardial interstitial matrix expansion, therefore, promoting myocardial apoptosis and necrosis, and eventually, leading to continuous myocardial injury.
In this study, it was found that the LV remodeling index (LV mass/volume ratio) was increased after the modeling of 4.5 months. We also found that LVM was increased after the modeling of 1.5 months. Similar results were reported by Sorensen et al. [18, 19] in a large cohort of patients examined with CMR. In their entire cohort, Sorensen et al. found that LVM was generally higher in these patients with FGF-23 above the median. FGF-23 has been shown to directly affect myocardial cells and induce left ventricular hypertrophy . In our diabetic animal model, the increase in LVM and left ventricular wall hypertrophy in gross specimens further confirmed the previous findings. According to relevant reports, the pathogenesis of diabetic left ventricular hypertrophy was also related to diabetic myocardial interstitial fibrosis and myocardial triglyceride accumulation [21, 22]. In our experiment, diffuse fibrosis of myocardial interstitium has been confirmed in the histological analysis, so next we will expand our sample size, and conduct anti-myocardial fibrosis therapy in diabetic pigs to observe the histological changes of isolated heart to verify whether the above treatment can protect or reverse myocardial damage.
EAT comprises adipocytes, stromo-vascular cells, neurons, and immune cells [23, 24], which is metabolically very active. The secretome of EAT disrupts cardiomyocyte metabolism , depresses cardiomyocyte contractile function  and alters expression of adhesion markers of primary cardiac endothelial cells . In our study, we also find the EAT in diabetic model was significantly increased at the 6th months diabetic modeling. It's been reported previously that the amount of EAT is increased in patients with T2DM  and the high level of EAT is associated with cardiac systolic dysfunction in patients with T2DM . Thus, whether dysfunction of cardiomyocyte contractile function (LVGLS) at the 6th months modeling can be ascribed by the pure effect of DM or by a confounding effect of DM and EAT still requires further study. As the myocardium consists of 3 layers , and because the orientation of left ventricle subendocardial muscle fibers is longitudinal, the subendocardial layer is more susceptible to ischemia, toxic, or other metabolic factors [30, 31]. The decrease of LVGLS indicates the subendocardial dysfunction appeared earlier than the global cardiac dysfunction assessed by LVEF in those pigs. Our results show that CMR-FT is a very sensitive tool to detect subtle endocardial impairment in the early stages of DM. In addition, this study also found that the longer the course of diabetes, the lower the value of LVGLS, indicating a progressive damage of the endocardial muscle. Therefore, effective reduction of blood glucose level is essential to protect the myocardium. In the following experiments, we will also conduct hypoglycemic treatment on diabetic pigs to observe whether myocardial mechanical injury can be reversed or ameliorated, so as to provide an important theoretical basis for clinical improvement of cardiac function in patients with DCM.
In this study, three limitations should be considered. First, our animal sample size was small, which greatly reduced the power of the study and did not allow us to draw generalized conclusions. We will continue to expand our sample size in our future studies on this topic. Second, our study was unable to carry out serial histological validation evaluation at various timepoints in type 1.5 DM animal models because pigs are large animals and limited by many experimental conditions. Third, impaired myocardial perfusion is one of the key characteristics of diabetic cardiomyopathy. However, due to technical reasons, we failed to do stress myocardial perfusion after many attempts. In the next experiment, we'll explore this myocardial perfusion imaging technique.
In summary, our study suggests that increases in LVM, myocardial native T1, ECV, and EAT can be detected prior to a decline in left ventricular systolic function as diabetes progresses in diabetic mini-pigs. LVGLS is impaired gradually with the prolonged course of diabetes. Whether LV systolic dysfunction can be ascribed to the true effect of DM or to a confounding effect of DM and EAT still requires further study. T1 mapping and myocardial strain analysis are promising method in detecting subtle myocardial dysfunction in the early stages of DM.
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
Type 2 diabetes mellitus
Cardiovascular magnetic resonance feature tracking
Left ventricular end-diastolic volume
Left ventricular end-systolic volume
Left ventricular ejection fraction
Left ventricular mass
Left atrial volume
Left ventricular global radial strain
Left ventricular global circumferential strain
Left ventricular global longitudinal strain
Epicardial adipose tissue
Intra-class correlation coefficient
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004;27(3):699–703.
Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34(1):29–34.
Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med. 2008;121(9):748–57.
Greulich S, Maxhera B, Vandenplas G, de Wiza DH, Smiris K, Mueller H, Heinrichs J, Blumensatt M, Cuvelier C, Akhyari P, et al. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation. 2012;126(19):2324–34.
Liu X, Yang ZG, Gao Y, Xie LJ, Jiang L, Hu BY, Diao KY, Shi K, Xu HY, Shen MT, et al. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study. Cardiovasc Diabetol. 2018;17(1):139.
Smith BM, Dorfman AL, Yu S, Russell MW, Agarwal PP, Ghadimi Mahani M, Lu JC. Relation of strain by feature tracking and clinical outcome in children, adolescents, and young adults with hypertrophic cardiomyopathy. Am J Cardiol. 2014;114(8):1275–80.
Hinojar R, Fernández-Golfín C, González-Gómez A, Rincón LM, Plaza-Martin M, Casas E, García-Martín A, Fernandez-Mendez MA, Esteban A, Nacher JJJ, et al. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis. Int J Cardiol. 2017;249:467–72.
Cao Y, Zeng W, Cui Y, Kong X, Wang M, Yu J, Zhang S, Song J, Yan X, Greiser A, et al. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain. Cardiovasc Diabetol. 2018;17(1):7.
Hara H, Lin YJ, Zhu X, Tai HC, Ezzelarab M, Balamurugan AN, Bottino R, Houser SL, Cooper DK. Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas. 2008;36(1):31–8.
Park JJ, Kim SH, Kim MA, Chae IH, Choi DJ, Yoon CH. Effect of hyperglycemia on myocardial perfusion in diabetic porcine models and humans. J Korean Med Sci. 2019;34(29):e202.
Cai S, Wald R, Deva DP, Kiaii M, Ng MY, Karur GR, Bello O, Li ZJ, Leipsic J, Jimenez-Juan L, et al. Cardiac MRI measurements of pericardial adipose tissue volumes in patients on in-centre nocturnal hemodialysis. J Nephrol. 2020;33(2):355–63.
Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, Taylor AJ. Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging. 2015;16(1):14–22.
Sorensen MH, Bojer AS, Pontoppidan JRN, Broadbent DA, Plein S, Madsen PL, Gaede P. Reduced myocardial perfusion reserve in Type 2 diabetes is caused by increased perfusion at rest and decreased maximal perfusion during stress. Diabetes Care. 2020;43(6):1285–92.
Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002;51(6):1938–48.
Khan JN, Wilmot EG, Leggate M, Singh A, Yates T, Nimmo M, Khunti K, Horsfield MA, Biglands J, Clarysse P, et al. Subclinical diastolic dysfunction in young adults with Type 2 diabetes mellitus: a multiparametric contrast-enhanced cardiovascular magnetic resonance pilot study assessing potential mechanisms. Eur Heart J Cardiovasc Imaging. 2014;15(11):1263–9.
Zeng M, Zhang N, He Y, Wen Z, Wang Z, Zhao Y, Greiser A, An J, Zhang T, Jing B, et al. Histological validation of cardiac magnetic resonance T(1) mapping for detecting diffuse myocardial fibrosis in diabetic rabbits. J Magn Reson Imaging. 2016;44(5):1179–85.
Sorensen MH, Bojer AS, Jorgensen NR, Broadbent DA, Plein S, Madsen PL, Gaede P. Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics. Cardiovasc Diabetol. 2020;19(1):158.
Sorensen MH, Bojer AS, Broadbent DA, Plein S, Madsen PL, Gaede P. Cardiac perfusion, structure, and function in type 2 diabetes mellitus with and without diabetic complications. Eur Heart J Cardiovasc Imaging. 2020;21(8):887–95.
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393–408.
Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83(6):1849–65.
Levelt E, Mahmod M, Piechnik SK, Ariga R, Francis JM, Rodgers CT, Clarke WT, Sabharwal N, Schneider JE, Karamitsos TD, et al. Relationship between left ventricular structural and metabolic remodeling in Type 2 diabetes. Diabetes. 2016;65(1):44–52.
Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015;11(6):363–71.
Antonopoulos AS, Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol. 2017;595(12):3907–17.
Blumensatt M, Fahlbusch P, Hilgers R, Bekaert M. Herzfeld de Wiza D, Akhyari P, Ruige JB, Ouwens DM. Secretory products from epicardial adipose tissue from patients with type 2 diabetes impair mitochondrial β-oxidation in cardiomyocytes via activation of the cardiac renin-angiotensin system and induction of miR-208a. Basic Res Cardiol. 2017;112(1):2.
Chechi K, Voisine P, Mathieu P, Laplante M, Bonnet S, Picard F, Joubert P, Richard D. Functional characterization of the Ucp1-associated oxidative phenotype of human epicardial adipose tissue. Sci Rep. 2017;7(1):15566.
Li Y, Liu B, Li Y, Jing X, Deng S, Yan Y, She Q. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2019;18(1):3.
Christensen RH, Hansen CS, von Scholten BJ, Jensen MT, Pedersen BK, Schnohr P, Vilsbøll T, Rossing P, Jørgensen PG. Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes. Diabetes Obes Metab. 2019;21(8):2006–11.
Ishizu T, Seo Y, Baba M, Machino T, Higuchi H, Shiotsuka J, Noguchi Y, Aonuma K. Impaired subendocardial wall thickening and post-systolic shortening are signs of critical myocardial ischemia in patients with flow-limiting coronary stenosis. Circ J. 2011;75(8):1934–41.
Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23(4):351–369; quiz 453–355.
Qiao YY, Zeng M, Li RJ, Leng ZT, Yang J, Yang Y. Layer-specific myocardial strain analysis: investigation of regional deformation in a rabbit model of diabetes mellitus during different stages. Med Ultrason. 2016;18(3):339–44.
We thank all of our colleagues for their assistance with the current study.
This study was funded by Hubei Province Key Laboratory of Molecular Imaging (02.03.2018-90; F016.02004.20003.068) and Union Hospital, Huazhong University of Science and Technology (02.03.2019-101).The funders only provide funding and have no influence on study design, data collection, data analysis, data interpretation, decision to publish, or writing the manuscript.
Ethics approval and consent to participate
This study was approved by Institutional Animal Care and Use Committee, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. All animal experiments were executed conforming to the “Guide for the Care and Use of Laboratory Animals” and in compliance with the ARRIVE guidelines.
Consent for publication
All authors declared that: there is no conflict of interest existing in the submission of this manuscript, and all authors approved the article for publication.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Shao, G., Cao, Y., Cui, Y. et al. Multiparametric CMR imaging of myocardial structure and function changes in diabetic mini-pigs with preserved LV function: a preliminary study. BMC Cardiovasc Disord 22, 143 (2022). https://doi.org/10.1186/s12872-022-02597-7
- Diabetes mellius
- Cardiac magnetic resonance
- Epicardial adipose tissue
- Feature tracking